Figure 1 — HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma

Research Paper|Volume 16, Issue 5|pp. 4841–4861

HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma

Back to articleFigure 1(1 of 8)

100%

Figure 1.Analyses of HOXC9 expression and the diagnostic and prognostic value in LUAD. (A) The expression distribution of HOXC9 in tumor tissues and normal tissues with TIMER2, respectively; (B–E) The correlation between HOXC9 expression and clinical variables of LUAD; (F) The HOXC9 protein level in adjacent healthy tissue; (G) and in the tumor tissue; (H) The diagnostic value of HOXC9 in LUAD; (I) The OS analysis of HOXC9 in LUAD patients. (*, P<0.05; **, P<0.01; ***, P<0.001).